| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |